RealTime CMV
Device
Abbott Laboratories
Total Payments
$386,051
Transactions
18
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $292,694 | 14 | 1 |
| 2019 | $12,590 | 1 | 0 |
| 2018 | $5,766 | 1 | 0 |
| 2017 | $75,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $201,901 | 13 | 52.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $174,045 | 3 | 45.1% |
| Consulting Fee | $10,078 | 1 | 2.6% |
| Food and Beverage | $27.45 | 1 | 0.0% |
Payments by Type
Research
$201,901
13 transactions
General
$184,150
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Impact of low level CMV viremia in reactivation and CMV disease in allogenic hematopoietic cell transplant recipients | Abbott Laboratories | $80,766 | 0 |
| Abbott Molecular Alinity m HIV-1 Testing Study | Abbott Laboratories | $38,509 | 0 |
| Abbott RealTime SARS-CoV-2 Reproducibility and Clinical Testing Study | Abbott Laboratories | $26,044 | 0 |
| Alinity m Resp-4-Plex Reproducibility and Clinical Testing Study | Abbott Laboratories | $23,992 | 0 |
| Impact of Low Level CMV viremia in reactivation and CMV disease in allogenic hematopoietic cell transplant recipients | Abbott Laboratories | $12,590 | 0 |
| Alinity m CMV Reproducibility and Clinical Testing Study | Abbott Laboratories | $10,000 | 0 |
| Alinity m SARS-CoV-2 Reproducibility and Testing Study | Abbott Laboratories | $10,000 | 0 |
Top Doctors Receiving Payments for RealTime CMV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Detroit, MI | $386,023 | 17 |
| , M.D | Allergy & Immunology | Silver Spring, MD | $27.45 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $386,051
Product Information
- Type Device
- Total Payments $386,051
- Total Doctors 1
- Transactions 18
About RealTime CMV
RealTime CMV is a device associated with $386,051 in payments to 1 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2021. In 2021, $292,694 was paid across 14 transactions to 1 doctors.
The most common payment nature for RealTime CMV is "Unspecified" ($201,901, 52.3% of total).
RealTime CMV is associated with 7 research studies, including "Impact of low level CMV viremia in reactivation and CMV disease in allogenic hematopoietic cell transplant recipients" ($80,766).